Difficulty: Medium
Average Score: 91%
Testbank
The therapeutic action of monoamine oxidase inhibitors (MAOIs) blocks neurotransmitter reuptake, causing what effect?
Correct answer
A
Rationale
Increased concentration of neurotransmitters in the synaptic gap occurs due to the action of monoamine oxidase inhibitors (MAOIs). MAOIs inhibit the enzyme that breaks down neurotransmitters, leading to their accumulation in the synaptic cleft, which enhances neurotransmission and can alleviate symptoms of depression or anxiety.
B: Decreased concentration of neurotransmitters in serum does not apply here, as MAOIs increase neurotransmitter levels rather than decrease them, affecting synaptic availability rather than serum concentration.
C: Destruction of receptor sites is not relevant, as MAOIs do not target receptor sites directly; instead, they focus on the metabolic breakdown of neurotransmitters, preserving their availability in the synapse.
D: Limbic system stimulation does not specifically describe the action of MAOIs, as the increase in neurotransmitter concentration primarily affects synaptic activity and neurotransmission rather than directly stimulating specific brain regions.
B: Decreased concentration of neurotransmitters in serum does not apply here, as MAOIs increase neurotransmitter levels rather than decrease them, affecting synaptic availability rather than serum concentration.
C: Destruction of receptor sites is not relevant, as MAOIs do not target receptor sites directly; instead, they focus on the metabolic breakdown of neurotransmitters, preserving their availability in the synapse.
D: Limbic system stimulation does not specifically describe the action of MAOIs, as the increase in neurotransmitter concentration primarily affects synaptic activity and neurotransmission rather than directly stimulating specific brain regions.